1-150308146-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000614145.5(MRPS21):c.182G>A(p.Arg61Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000646 in 1,610,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R61W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000614145.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPS21 | NM_031901.6 | c.182G>A | p.Arg61Gln | missense_variant | 3/3 | ENST00000614145.5 | NP_114107.2 | |
MRPS21 | NM_018997.4 | c.182G>A | p.Arg61Gln | missense_variant | 2/2 | NP_061870.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPS21 | ENST00000614145.5 | c.182G>A | p.Arg61Gln | missense_variant | 3/3 | 1 | NM_031901.6 | ENSP00000480129 | P1 | |
MRPS21 | ENST00000581066.2 | c.182G>A | p.Arg61Gln | missense_variant | 2/2 | 1 | ENSP00000461930 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152114Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251176Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135750
GnomAD4 exome AF: 0.0000665 AC: 97AN: 1457924Hom.: 0 Cov.: 34 AF XY: 0.0000759 AC XY: 55AN XY: 724362
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152114Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.182G>A (p.R61Q) alteration is located in exon 2 (coding exon 2) of the MRPS21 gene. This alteration results from a G to A substitution at nucleotide position 182, causing the arginine (R) at amino acid position 61 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at